Upstream Bioprocessing 2021

Overview of major AAV production platforms

Cell & Gene Therapy Insights 2021; 7(9), 1073–1076


Published: 24 September 2021
Jote Bulcha

Jote Bulcha

University of Massachusetts Medical School

“The current AAV-based viral vector production methods cannot meet demand for conducting large-scale clinical trials and commercial applications. Therefore, there is an urgent need to develop innovative AAV production schemes to turn the promise of gene therapy treatments into a reality.”